scholarly article | Q13442814 |
P356 | DOI | 10.4269/AJTMH.17-0359 |
P8608 | Fatcat ID | release_fjob6zfhvzf7nhl2eef4pdxpxi |
P932 | PMC publication ID | 5817778 |
P698 | PubMed publication ID | 29016339 |
P50 | author | Marcelo Ribeiro-Alves | Q48040879 |
Josué da Costa Lima-Junior | Q56555271 | ||
Cláudio Tadeu Daniel-Ribeiro | Q60012093 | ||
Pierre Druilhe | Q80328511 | ||
P2093 | author name string | Fátima Santos | |
Daniel Camus | |||
Daiana De Souza Perce-Da-Silva | |||
Dalma Maria Banic | |||
Evelyn Kety Pratt Riccio | |||
Joseli Oliveira-Ferreira | |||
Lilian Rose Pratt-Riccio | |||
Mercia Arruda | |||
P2860 | cites work | Major Histocompatibility Complex and Malaria: Focus on Plasmodium vivax Infection | Q26767472 |
Immunoglobulin class switching | Q28285566 | ||
Opsonic phagocytosis of Plasmodium falciparum merozoites: mechanism in human immunity and a correlate of protection against malaria | Q31169310 | ||
Long-term clinical protection from falciparum malaria is strongly associated with IgG3 antibodies to merozoite surface protein 3. | Q33305467 | ||
The quantity and quality of African children's IgG responses to merozoite surface antigens reflect protection against Plasmodium falciparum malaria | Q33512926 | ||
Analysis of human antibodies to erythrocyte binding antigen 175 of Plasmodium falciparum | Q33591313 | ||
Isotypic analysis of Plasmodium falciparum-specific antibodies and their relation to protection in Madagascar | Q33612549 | ||
Malaria in Brazil: an overview | Q33939774 | ||
DDX39B (BAT1), TNF and IL6 gene polymorphisms and association with clinical outcomes of patients with Plasmodium vivax malaria | Q33957344 | ||
High immunoglobulin G2 (IgG2) and low IgG4 levels are associated with human resistance to Plasmodium falciparum malaria | Q34003525 | ||
Antibody recognition of Plasmodium falciparum infected red blood cells by symptomatic and asymptomatic individuals in the Brazilian Amazon. | Q34142748 | ||
Influence of HLA-DRB1 and HLA-DQB1 alleles on IgG antibody response to the P. vivax MSP-1, MSP-3α and MSP-9 in individuals from Brazilian endemic area. | Q34287358 | ||
Target antigen, age, and duration of antigen exposure independently regulate immunoglobulin G subclass switching in malaria | Q34301187 | ||
Analysis of human antibodies to erythrocyte binding antigen 175 peptide 4 of Plasmodium falciparum | Q34537136 | ||
B cell epitope mapping and characterization of naturally acquired antibodies to the Plasmodium vivax merozoite surface protein-3α (PvMSP-3α) in malaria exposed individuals from Brazilian Amazon | Q34726966 | ||
Effect of transmission intensity and age on subclass antibody responses to Plasmodium falciparum pre-erythrocytic and blood-stage antigens | Q34778078 | ||
Asymptomatic infection in individuals from the municipality of Barcelos (Brazilian Amazon) is not associated with the anti-Plasmodium falciparum glycosylphosphatidylinositol antibody response | Q34987487 | ||
Measuring naturally acquired immune responses to candidate malaria vaccine antigens in Ghanaian adults | Q35093445 | ||
Antibodies to the Plasmodium falciparum antigens circumsporozoite protein, thrombospondin-related adhesive protein, and liver-stage antigen 1 vary by ages of subjects and by season in a highland area of Kenya | Q35165581 | ||
Humoral and cell-mediated immunity to the Plasmodium falciparum ring-infected erythrocyte surface antigen in an adult population exposed to highly endemic malaria | Q35386488 | ||
THE PASSIVE TRANSFER OF HUMAN MALARIAL IMMUNITY. | Q35420711 | ||
Prognostic value of anti-Plasmodium falciparum-specific immunoglobulin G3, cytokines, and their soluble receptors in West African patients with severe malaria | Q35552983 | ||
Age-dependent IgG subclass responses to Plasmodium falciparum EBA-175 are differentially associated with incidence of malaria in Mozambican children | Q35739071 | ||
Genetic Resistance to Malaria Is Associated With Greater Enhancement of Immunoglobulin (Ig)M Than IgG Responses to a Broad Array of Plasmodium falciparum Antigens | Q36042702 | ||
Association between protection against clinical malaria and antibodies to merozoite surface antigens in an area of hyperendemicity in Myanmar: complementarity between responses to merozoite surface protein 3 and the 220-kilodalton glutamate-rich pro | Q36227049 | ||
Humoral responses to plasmodium falciparum blood-stage antigens and association with incidence of clinical malaria in children living in an area of seasonal malaria transmission in Burkina Faso, West Africa. | Q36421572 | ||
Anti-Plasmodium falciparum invasion ligand antibodies in a low malaria transmission region, Loreto, Peru | Q36531268 | ||
Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria | Q36594057 | ||
Humoral immune response to Plasmodium falciparum vaccine candidate GMZ2 and its components in populations naturally exposed to seasonal malaria in Ethiopia | Q36741193 | ||
High prevalence of asymptomatic malaria in gold mining areas in Brazil | Q48004091 | ||
Immunologic responses to soluble exoantigens of Plasmodium falciparum in Gabonese children exposed to continuous intense infection | Q48005617 | ||
Correlation of high levels of antibodies to multiple pre-erythrocytic Plasmodium falciparum antigens and protection from infection. | Q48012112 | ||
Evaluation of host humoral antibody production against Plasmodium falciparum recombinant circumsporozoite antigen in Nigerian children. | Q48024856 | ||
Detection and identification of the four malaria parasite species infecting humans by PCR amplification. | Q48030204 | ||
Identification of recombinant filarial proteins capable of inducing polyclonal and antigen-specific IgE and IgG4 antibodies | Q48071892 | ||
Automated multiple peptide synthesis | Q52411545 | ||
HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation | Q67522337 | ||
Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP) | Q71608623 | ||
Antibody responses to the merozoite surface protein-1 complex in cerebral malaria patients in India | Q36800846 | ||
Evaluation of the genetic polymorphism of Plasmodium falciparum P126 protein (SERA or SERP) and its influence on naturally acquired specific antibody responses in malaria-infected individuals living in the Brazilian Amazon | Q36835626 | ||
Plasmodium falciparum malaria: evidence for an isotype imbalance which may be responsible for delayed acquisition of protective immunity | Q36943252 | ||
Antibodies to pre-erythrocytic Plasmodium falciparum antigens and risk of clinical malaria in Kenyan children | Q37023939 | ||
Immunoglobulin G subclass-specific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illness | Q37099503 | ||
Immunity to malaria: more questions than answers | Q37194482 | ||
Cellular and humoral immune responses against the Plasmodium vivax MSP-1₁₉ malaria vaccine candidate in individuals living in an endemic area in north-eastern Amazon region of Brazil | Q37363110 | ||
Human leukocyte antigen class II alleles influence levels of antibodies to the plasmodium falciparum asexual-stage apical membrane antigen 1 but not to merozoite surface antigen 2 and merozoite surface protein 1 | Q37426223 | ||
Antibodies to the N-terminal block 2 of plasmodium falciparum merozoite surface protein 1 are associated with protection against clinical malaria | Q37582802 | ||
Cross-reactive anti-PfCLAG9 antibodies in the sera of asymptomatic parasite carriers of Plasmodium vivax | Q37682153 | ||
Impact of age of first exposure to Plasmodium falciparum on antibody responses to malaria in children: a randomized, controlled trial in Mozambique | Q37702603 | ||
Serum IgG3 to the Plasmodium falciparum merozoite surface protein 2 is strongly associated with a reduced prospective risk of malaria | Q39247931 | ||
High levels of serum antibodies to merozoite surface protein 2 of Plasmodium falciparum are associated with reduced risk of clinical malaria in coastal Kenya | Q39362550 | ||
Asymptomatic infection with Plasmodium falciparum and Plasmodium vivax in the Brazilian Amazon Basin: to treat or not to treat? | Q39504456 | ||
Urban malaria in the Brazilian Western Amazon Region I: high prevalence of asymptomatic carriers in an urban riverside district is associated with a high level of clinical malaria | Q39504463 | ||
Dynamics of the antibody response to Plasmodium falciparum infection in African children | Q39589730 | ||
A longitudinal investigation of IgG and IgM antibody responses to the merozoite surface protein-1 19-kiloDalton domain of Plasmodium falciparum in pregnant women and infants: associations with febrile illness, parasitemia, and anemia. | Q40640896 | ||
Relationship between humoral response to Plasmodium falciparum merozoite surface antigen-2 and malaria morbidity in a highly endemic area of Papua New Guinea | Q40694087 | ||
Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen (PfMSP1) of Plasmodium falciparum are associated with reduced malaria morbidity. | Q40734085 | ||
Pattern of antibodies to the Duffy binding like domain of Plasmodium falciparum antigen Pf332 in Senegalese individuals | Q41392065 | ||
Is Fc gamma receptor IIA (FcγRIIA) polymorphism associated with clinical malaria and Plasmodium falciparum specific antibody levels in children from Burkina Faso? | Q41635798 | ||
Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages | Q41835030 | ||
Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes | Q42938913 | ||
The epidemiology of malaria in Rondonia (Western Amazon region, Brazil): study of a riverine population | Q44140387 | ||
Synthetic malaria peptide vaccine elicits high levels of antibodies in vaccinees of defined HLA genotypes | Q44144189 | ||
Differential acquisition of human antibody responses to Plasmodium falciparum according to intensity of exposure to Anopheles bites | Q44164631 | ||
Antibodies against the Plasmodium falciparum glutamate-rich protein from naturally exposed individuals living in a Brazilian malaria-endemic area can inhibit in vitro parasite growth | Q44575916 | ||
Pattern of immunoglobulin isotype response to Plasmodium falciparum blood-stage antigens in individuals living in a holoendemic area of Senegal (Dielmo, west Africa). | Q44710649 | ||
Lymphocyte proliferation and antibody responses to Plasmodium falciparum liver-stage antigen-1 in a highland area of Kenya with seasonal variation in malaria transmission. | Q45068855 | ||
The presence of the HLA class II allele DPB1*0501 in ethnic Thais correlates with an enhanced vaccine-induced antibody response to a malaria sporozoite antigen | Q45157941 | ||
Influence of HLA-DRB1 alleles on antibody responses to PfCP-2.9-immunized and naturally infected individuals. | Q46086616 | ||
Differential antibody responses to Plasmodium falciparum invasion ligand proteins in individuals living in malaria-endemic areas in Brazil and Cameroon. | Q46298357 | ||
Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19-kDa C-terminal fragment of the merozoite surface antigen, PfMSP-1. | Q46334562 | ||
Antibody response profiles induced by Plasmodium falciparum glutamate-rich protein in naturally exposed individuals from a Brazilian area endemic for malaria. | Q46339260 | ||
IgG3 antibodies to Plasmodium falciparum merozoite surface protein 2 (MSP2): increasing prevalence with age and association with clinical immunity to malaria. | Q47830190 | ||
Immune response and lack of immune response to Plasmodium falciparum P126 antigen and its amino-terminal repeat in malaria-infected humans | Q47833716 | ||
Fc gamma receptor IIa (CD32) polymorphism and antibody responses to asexual blood-stage antigens of Plasmodium falciparum malaria in Sudanese patients | Q47836433 | ||
Interleukin-21 is associated with IgG1 and IgG3 antibodies to erythrocyte-binding antigen-175 peptide 4 of Plasmodium falciparum in Gabonese children with acute falciparum malaria | Q47861367 | ||
Genetic control of the immune response to a synthetic vaccine against Plasmodium falciparum | Q47872379 | ||
Natural human IgG subclass antibodies to Plasmodium falciparum blood stage antigens and their relation to malaria resistance in an endemic area of Thailand. | Q47889819 | ||
Naturally acquired immunoglobulin (Ig)G subclass antibodies to crude asexual Plasmodium falciparum lysates: evidence for association with protection for IgG1 and disease for IgG2. | Q47900627 | ||
Human leukocyte antigen class II control of the immune response to p126-derived amino terminal peptide from Plasmodium falciparum | Q47911320 | ||
High prevalence of asymptomatic Plasmodium vivax and Plasmodium falciparum infections in native Amazonian populations | Q47911926 | ||
Association between naturally acquired antibodies to erythrocyte-binding antigens of Plasmodium falciparum and protection from malaria and high-density parasitemia | Q47954510 | ||
HLA class II and antibody responses to circumsporozoite protein repeats of P. vivax (VK210, VK247 and P. vivax-like) in individuals naturally exposed to malaria | Q47990902 | ||
Influence of HLA-DRB-1 alleles on the production of antibody against CSP, MSP-1, AMA-1, and DBP in Brazilian individuals naturally infected with Plasmodium vivax | Q47995600 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Plasmodium falciparum | Q311383 |
P304 | page(s) | 1581-1592 | |
P577 | publication date | 2017-09-18 | |
P1433 | published in | American Journal of Tropical Medicine and Hygiene | Q15766943 |
P1476 | title | Synthetic Antigens Derived from Plasmodium falciparum Sporozoite, Liver, and Blood Stages: Naturally Acquired Immune Response and Human Leukocyte Antigen Associations in Individuals Living in a Brazilian Endemic Area | |
P478 | volume | 97 |
Q90235828 | Evaluation of Plasmodium falciparum MSP10 and its development as a serological tool for the Peruvian Amazon region | cites work | P2860 |
Search more.